New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Krystal Biotech, Inc.
KRYS
Shape
US Flag

NASDAQ

EPS improving

EPS improving

5B

Biotechnology

Next Earning date - 04 Nov 2024

5B

Biotechnology

Next Earning date - 04 Nov 2024

179.19USD
Shape2.37 ( 1.34%)
favorite-chart

Relative Strenght

66
favorite-chart

Volume Buzz

-22%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

18%

Quote Panel

Shape
Updated October 19, 2024
1W -0.22 % 1M -2.70 % 3M -13.37 % 1Y 64.45 %

Key Metrics

Shape
  • Market Cap

    5.15B


  • Shares Outstanding

    28.73M


  • Share in Float

    24.29M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    179.19


  • Average Volume

    236606


  • Beta

    0.818


  • Range

    93.95-219.34


  • Industry

    Biotechnology


  • Website

    https://www.krystalbio.com


  • Sector

    Healthcare


Fundamentals

Shape

344.60x

P/E Ratio

30.97x

P/S Ratio

6.11x

P/B Ratio

0.0

Debt/Equity

63.7%

Net Margin

$4.0

EPS

How KRYS compares to sector?

P/E Ratio

Relative Strength

Shape

KRYS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

downgrade

Previous: Buy

2024-08-05

Now: Neutral

Goldman Sachs

upgrade

Previous: Not converted

2023-02-28

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.17
vs -0.70

Q4.22

arrow
arrow

N/A

-1.25
vs -0.94

Q1.23

arrow
arrow

N/A

-1.76
vs -0.99

Q2.23

arrow
arrow

N/A

-1.25
vs -1.10

Q3.23

arrow
arrow

N/A

-0.67
vs -1.17

Q4.23

arrow
arrow

+124%

0.3
vs -1.25

Q1.24

arrow
arrow

+102%

0.03
vs -1.76

Q2.24

arrow
arrow

+169%

0.86
vs -1.25

Q3.24

arrow
arrow

+253%

1.02
vs -0.67

Q4.24

arrow
arrow

+261%

1.08
vs 0.3

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

8.6M  vs NA

Q4.23

arrow
arrow

NA

42.1M  vs NA

Q1.24

arrow
arrow

NA

45.3M  vs NA

Q2.24

arrow
arrow

NA

70.3M  vs NA

Q3.24

arrow
arrow

+884%

84.2M  vs 8.6M

Q4.24

arrow
arrow

+128%

95.9M  vs 42.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-6%

-0.06
vs -0.05

Q4.22

arrow
arrow

-6%

-0.06
vs -0.06

Q1.23

arrow
arrow

-9%

-0.09
vs -0.06

Q2.23

arrow
arrow

-5%

-0.05
vs -0.09

Q3.23

arrow
arrow

+11%

0.11
vs -0.05

Q4.23

arrow
arrow

+1%

0.01
vs 0.11

Q1.24

arrow
arrow

+0%

0
vs 0.01

Q2.24

arrow
arrow

+2%

0.02
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

152

152
vs 137

11%

Q4.22

arrow
arrow

160

160
vs 152

5%

Q1.23

arrow
arrow

169

169
vs 160

6%

Q2.23

arrow
arrow

197

197
vs 169

17%

Q3.23

arrow
arrow

199

199
vs 197

1%

Q4.23

arrow
arrow

203

203
vs 199

2%

Q1.24

arrow
arrow

253

253
vs 203

25%

Q2.24

arrow
arrow

253

253
vs 253

NA

Earnings Growth

Latest News